MorphoSys (ETR:MOR – Get Rating) has been given a €24.00 ($25.81) price target by stock analysts at The Goldman Sachs Group in a research report issued on Friday, Borsen Zeitung reports. The Goldman Sachs Group’s target price points to a potential upside of 15.33% from the company’s current price. Several other brokerages also recently weighed […]